Xiaobo Wang

2.4k total citations · 2 hit papers
45 papers, 1.8k citations indexed

About

Xiaobo Wang is a scholar working on Molecular Biology, Genetics and Complementary and alternative medicine. According to data from OpenAlex, Xiaobo Wang has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Genetics and 6 papers in Complementary and alternative medicine. Recurrent topics in Xiaobo Wang's work include Medicinal Plants and Bioactive Compounds (9 papers), High Altitude and Hypoxia (8 papers) and Mitochondrial Function and Pathology (6 papers). Xiaobo Wang is often cited by papers focused on Medicinal Plants and Bioactive Compounds (9 papers), High Altitude and Hypoxia (8 papers) and Mitochondrial Function and Pathology (6 papers). Xiaobo Wang collaborates with scholars based in China, South Korea and Germany. Xiaobo Wang's co-authors include Xianli Meng, Ya Hou, Xiaopeng Ai, Jinrong Bai, Yi Zhang, Xiaorui Chen, Yunsen Zhang, Ce Tang, Yi Zhang and Xianli Meng and has published in prestigious journals such as Chemical Reviews, Chemical Engineering Journal and Environmental Pollution.

In The Last Decade

Xiaobo Wang

43 papers receiving 1.8k citations

Hit Papers

Gallic acid: Pharmacological activities and molecular mec... 2020 2026 2022 2024 2020 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobo Wang China 21 680 443 362 167 157 45 1.8k
Caifang Gao China 21 851 1.3× 200 0.5× 175 0.5× 228 1.4× 218 1.4× 42 1.9k
Nasimudeen R. Jabir Saudi Arabia 26 693 1.0× 232 0.5× 288 0.8× 183 1.1× 83 0.5× 69 2.3k
Zhongwen Yuan China 22 660 1.0× 267 0.6× 238 0.7× 63 0.4× 205 1.3× 59 1.5k
Martina Perše Slovenia 24 934 1.4× 229 0.5× 283 0.8× 82 0.5× 147 0.9× 47 2.6k
Wei Fu China 26 1.0k 1.5× 570 1.3× 371 1.0× 84 0.5× 99 0.6× 100 2.3k
Yiqiong Pu China 20 462 0.7× 184 0.4× 158 0.4× 137 0.8× 184 1.2× 32 1.4k
Menaka C. Thounaojam India 28 705 1.0× 179 0.4× 367 1.0× 173 1.0× 228 1.5× 80 2.2k
Yongqi Liu China 24 711 1.0× 144 0.3× 227 0.6× 200 1.2× 110 0.7× 145 2.0k
Xiaobin Pang China 25 957 1.4× 181 0.4× 598 1.7× 121 0.7× 154 1.0× 86 2.2k

Countries citing papers authored by Xiaobo Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Wang more than expected).

Fields of papers citing papers by Xiaobo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Wang. The network helps show where Xiaobo Wang may publish in the future.

Co-authorship network of co-authors of Xiaobo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Wang. A scholar is included among the top collaborators of Xiaobo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Wang. Xiaobo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Shijie, Wenjuan Li, Zejiao Li, et al.. (2025). PRMT5 encourages cell migration and metastasis of tongue squamous cell carcinoma through methylating ΔNp63α. Cell Death and Differentiation. 1 indexed citations
2.
Sun, Jiayi, Leyi Huang, Wenfeng Jia, et al.. (2025). Nanodelivery strategies modulating tumor stromal cells for reverting the immunosuppressive tumor microenvironment. Chinese Chemical Letters. 37(4). 112036–112036.
3.
Liu, Qilong, Zongwen Fu, Xiaobo Wang, et al.. (2025). Additive manufacturing of immiscible alloys: Breaking the preparation bottleneck and unlocking the property potential. Journal of Alloys and Compounds. 1027. 180544–180544. 3 indexed citations
5.
Jiang, Hong, Yi Zhang, Qipeng Zhao, et al.. (2023). Barrier Functional Integrity Recording on bEnd.3 Vascular Endothelial Cells <em>via</em> Transendothelial Electrical Resistance Detection. Journal of Visualized Experiments. 2 indexed citations
6.
Sun, Zhihao, et al.. (2023). Real-Time Detection of Dynamic Affinity between Biomolecules Using Surface Plasmon Resonance (SPR) Technology. Journal of Visualized Experiments. 1 indexed citations
7.
Yang, Hailing, Qiuyue Li, Ning Li, et al.. (2022). Protective Effect of Brassica rapa Polysaccharide against Acute High‐Altitude Hypoxia‐Induced Brain Injury and Its Metabolomics. Oxidative Medicine and Cellular Longevity. 2022(1). 3063899–3063899. 5 indexed citations
8.
Jiang, Hong, Yating Zhang, Yi Zhang, Xiaobo Wang, & Xianli Meng. (2022). An Updated Meta-Analysis Based on the Preclinical Evidence of Mechanism of Aconitine-Induced Cardiotoxicity. Frontiers in Pharmacology. 13. 900842–900842. 11 indexed citations
9.
Wang, Xiaobo, Yan Tang, Na Xie, et al.. (2022). Salidroside, a phenyl ethanol glycoside from Rhodiola crenulata, orchestrates hypoxic mitochondrial dynamics homeostasis by stimulating Sirt1/p53/Drp1 signaling. Journal of Ethnopharmacology. 293. 115278–115278. 30 indexed citations
10.
Yi, Qiong, et al.. (2022). Review of phytomedicine, phytochemistry, ethnopharmacology, toxicology, and pharmacological activities of Cymbopogon genus. Frontiers in Pharmacology. 13. 997918–997918. 30 indexed citations
11.
Ai, Xiaopeng, et al.. (2022). Berberis dictyophylla F. inhibits angiogenesis and apoptosis of diabetic retinopathy via suppressing HIF-1α/VEGF/DLL-4/Notch-1 pathway. Journal of Ethnopharmacology. 296. 115453–115453. 41 indexed citations
12.
Jiang, Shengnan, Fangfang Fan, Lu Yang, et al.. (2022). Salidroside attenuates high altitude hypobaric hypoxia-induced brain injury in mice via inhibiting NF-κB/NLRP3 pathway. European Journal of Pharmacology. 925. 175015–175015. 27 indexed citations
13.
Tang, Yan, Ya Hou, Yong Zeng, et al.. (2021). Salidroside attenuates CoCl2-simulated hypoxia injury in PC12 cells partly by mitochondrial protection. European Journal of Pharmacology. 912. 174617–174617. 30 indexed citations
14.
Zhang, Yunsen, Huimin Chen, Wenxiang Wang, et al.. (2021). The Underlying Molecular Mechanisms Involved in Traditional Chinese Medicine Smilax china L. for the Treatment of Pelvic Inflammatory Disease. Evidence-based Complementary and Alternative Medicine. 2021. 1–18. 10 indexed citations
16.
Ai, Xiaopeng, Xing Dong, Ying Guo, et al.. (2021). Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment. Purinergic Signalling. 17(2). 229–240. 4 indexed citations
17.
Wang, Xiaobo, et al.. (2020). Synthesis of Sea Cucumber Saponins with Antitumor Activities. The Journal of Organic Chemistry. 85(19). 12080–12096. 11 indexed citations
18.
Li, Ning, Ke Chen, Jinrong Bai, et al.. (2020). Tibetan medicine Duoxuekang ameliorates hypobaric hypoxia-induced brain injury in mice by restoration of cerebrovascular function. Journal of Ethnopharmacology. 270. 113629–113629. 20 indexed citations
19.
Fan, Fangfang, Yang Lü, Ning Li, et al.. (2020). Salidroside as a potential neuroprotective agent for ischemic stroke: a review of sources, pharmacokinetics, mechanism and safety. Biomedicine & Pharmacotherapy. 129. 110458–110458. 87 indexed citations
20.
Ai, Xiaopeng, Ya Hou, Xiaobo Wang, et al.. (2019). Amelioration of dry eye syndrome in db/db mice with diabetes mellitus by treatment with Tibetan Medicine Formula Jikan Mingmu Drops. Journal of Ethnopharmacology. 241. 111992–111992. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026